AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Becker, C Pohla, H Frankenberger, B Schuler, T Assenmacher, M Schendel, DJ Blankenstein, T
Citation: C. Becker et al., Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay, NAT MED, 7(10), 2001, pp. 1159-1162

Authors: Cayeux, S Qin, ZH Dorken, B Blankenstein, T
Citation: S. Cayeux et al., Decreased generation of anti-tumor immunity after intrasplenic immunization, EUR J IMMUN, 31(5), 2001, pp. 1392-1399

Authors: Seliger, B Wollscheid, U Momburg, F Blankenstein, T Huber, C
Citation: B. Seliger et al., Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells, CANCER RES, 61(3), 2001, pp. 1095-1099

Authors: Gladow, M Becker, C Blankenstein, T Uckert, W
Citation: M. Gladow et al., MLV-10A1 retrovirus pseudotype efficiently transduces primary human CD4(+)T lymphocytes, J GENE MED, 2(6), 2000, pp. 409-415

Authors: Qin, ZH Blankenstein, T
Citation: Zh. Qin et T. Blankenstein, CD4(+) T cell-mediated tumor rejection involves inhibition of angiogenesisthat is dependent on IFN gamma receptor expression by nonhematopoietic cells, IMMUNITY, 12(6), 2000, pp. 677-686

Authors: Uckert, W Becker, C Gladow, M Klein, D Kammertoens, T Pedersen, L Blankenstein, T
Citation: W. Uckert et al., Efficient gene transfer into primary human CD8(+) T lymphocytes by MuLV-10A1 retrovirus pseudotype, HUM GENE TH, 11(7), 2000, pp. 1005-1014

Authors: Schendel, DJ Frankenberger, B Jantzer, P Cayeux, S Nossner, E Willimsky, G Maget, B Pohla, H Blankenstein, T
Citation: Dj. Schendel et al., Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse, GENE THER, 7(23), 2000, pp. 2007-2014

Authors: Westermann, J Kopp, J Korner, I Richter, G Qin, Z Blankenstein, T Dorken, B Pezzutto, A
Citation: J. Westermann et al., Bcr/abl plus autologous dendritic cells for vaccination in chronic myeloidleukemia, BONE MAR TR, 25, 2000, pp. S46-S49

Authors: Pohla, H Frankenberger, B Stadlbauer, B Oberneder, R Hofstetter, A Willimsky, G Pezzutto, A Dorken, B Blankenstein, T Schendel, DJ
Citation: H. Pohla et al., Allogeneic vaccination for renal cell carcinoma: development and monitoring, BONE MAR TR, 25, 2000, pp. S83-S87

Authors: Willimsky, G Blankenstein, T
Citation: G. Willimsky et T. Blankenstein, Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors, CANCER RES, 60(3), 2000, pp. 685-692

Authors: Seliger, B Wollscheid, U Momburg, F Blankenstein, T Huber, C
Citation: B. Seliger et al., Coordinate downregulation of multiple MHC class I antigen processing genesin chemical-induced murine tumor cell lines of distinct origin, TISSUE ANTI, 56(4), 2000, pp. 327-336

Authors: Schuler, T Qin, ZH Ibe, S Noben-Trauth, N Blankenstein, T
Citation: T. Schuler et al., T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice, J EXP MED, 189(5), 1999, pp. 803-810

Authors: Cayeux, S Richter, G Becker, C Pezzutto, A Dorken, B Blankenstein, T
Citation: S. Cayeux et al., Direct and indirect T cell priming by dendritic cell vaccines, EUR J IMMUN, 29(1), 1999, pp. 225-234
Risultati: 1-13 |